Jane Street
DNA icon

Jane Street’s Ginkgo Bioworks DNA Stock Holding History

Jane Street’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-181,755
Closed -$1.51M – 11855
2025
Q4 		$1.51M Buy
181,755
+96,736
+114% +$1.04M ﹤0.01% 5327
2025
Q3 		$1.24M Buy
+85,019
New +$1.02M ﹤0.01% 5862
2025
Q2 		– Sell
-69,704
Closed -$540K – 9861
2025
Q1 		$397K Buy
+69,704
New +$710K ﹤0.01% 7282
2024
Q3 		– Sell
-124,533
Closed -$1.25M – 9711
2024
Q2 		$1.67M Buy
124,533
+72,794
+141% +$2.17M ﹤0.01% 4818
2024
Q1 		$2.4M Sell
51,739
-39,541
-43% -$2.05M ﹤0.01% 3811
2023
Q4 		$6.17M Buy
91,280
+50,557
+124% +$3.1M ﹤0.01% 2567
2023
Q3 		$2.95M Sell
40,723
-5,386
-12% -$431K ﹤0.01% 3400
2023
Q2 		$3.43M Buy
46,109
+8,899
+24% +$527K ﹤0.01% 3287
2023
Q1 		$1.98M Buy
37,210
+25,646
+222% +$1.63M ﹤0.01% 3842
2022
Q4 		$782K Sell
11,564
-5,267
-31% -$484K ﹤0.01% 5387
2022
Q3 		$2.1M Buy
16,831
+11,018
+190% +$1.31M ﹤0.01% 4132
2022
Q2 		$553K Buy
5,813
+4,291
+282% +$523K ﹤0.01% 6552
2022
Q1 		$245K Sell
1,522
-2,980
-66% -$580K ﹤0.01% 8717
2021
Q4 		$1.5M Buy
4,502
+4,048
+892% +$1.92M ﹤0.01% 5084
2021
Q3 		$210K Buy
+454
New +$221K ﹤0.01% 8767

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's DNA Position: Q1 2026 in Review

Jane Street sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 181,755 shares — an estimated $1.51M sold.

Jane Street first reported a position in DNA in Q3 2021 and held it in 15 quarters. The position peaked at $6.17M in Q4 2023. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Jane Street reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 181,755 Ginkgo Bioworks shares in Q1 2026, an estimated $1.51M.
  • Jane Street first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 15 quarters.
  • Jane Street's Ginkgo Bioworks position peaked at $6.17M in Q4 2023.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.